Dyne Therapeutics (NasdaqGS:DYN) FY Conference Transcript
Dyne Therapeutics (NasdaqGS:DYN) FY Conference September 08, 2025 09:15 AM ET Company ParticipantsMichael Ulz - Executive Director - Biotechnology Equity ResearchJohn Cox - CEO, President & DirectorErick Lucera - CFOMichael UlzAll right, good morning everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Bolts, one of the biotech analysts here, and it's my pleasure to introduce the team from Dyne Therapeutics, including John Cox to my immediate left, President and C ...